Trial intelligence / Profile preview

Noradrenaline, acetylcholine and NMDA modulation in conscious perception

NL-OMON48993Terminated

Sponsor
University of Amsterdam
Start
May 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of atomoxetine, donepezil and memantine, sponsored by University of Amsterdam. Primary endpoints: Behavioral reaction times, Behavioral performance scores and 3 more. Started May 2019; status: terminated.

02

Drugs

atomoxetinedonepezilmemantine

Beyond the preview

Go deeper on NL-OMON48993.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON48993.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call